Upregulation of Sirt1 in carbon-tetrachloride–induced acute liver injury

References

• Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., et al. (2007). Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100:1512–1521.
   PubMed Web of Science ®Google Scholar
• Avalos, J. L., Bever, K. M., Wolberger, C. (2005). Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell 17:855–868.
   PubMed Web of Science ®Google Scholar
• Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., Sinclair, D. A. (2002). Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem 277:45099–45107.
   PubMed Web of Science ®Google Scholar
• Chen, J, Zhou, Y, Mueller-Steiner, S, Chen, LF, Kwon, H, Yi, S, et al. (2005). SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 280:40364–40374.
   PubMed Web of Science ®Google Scholar
• Chung, S., Yao, H., Caito, S., Hwang, J. W., Arunachalam, G., Rahman, I. (2010). Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 501:79–90.
   PubMed Web of Science ®Google Scholar
• Colak, Y, Ozturk, O, Senates, E, Tuncer, I, Yorulmaz, E, Adali, G, et al. (2011). SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. Med Sci Monit 17:HY5–HY9.
   PubMed Web of Science ®Google Scholar
• Csiszar, A, Labinskyy, N, Podlutsky, A, Kaminski, PM, Wolin, MS, Zhang, C, et al. (2008). Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am J Physiol Heart Circ Physiol 294:H2721–H2735.
   PubMed Web of Science ®Google Scholar
• Czaja, M. J., Xu, J., Alt, E. (1995). Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 108:1849–1854.
   PubMed Web of Science ®Google Scholar
• das Neves, R. N., Carvalho, F., Carvalho, M., Fernandes, E., Soares, E., de Bastos, M. L., et al. (2004). Protective activity of hesperidin and lipoic acid against sodium arsenite acute toxicity in mice. Toxicol Pathol 32:527–535.
   PubMed Web of Science ®Google Scholar
• Donmez, G., Guarente, L. (2010). Aging and disease: connections to sirtuins. Aging Cell 9:285–290.
   PubMed Web of Science ®Google Scholar
• Erion, DM, Yonemitsu, S, Nie, Y, Nagai, Y, Gillum, MP, Hsiao, JJ, et al. (2009). SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats. Proc Natl Acad Sci U S A 106:11288–11293.
   PubMed Web of Science ®Google Scholar
• Furukawa, A., Tada-Oikawa, S., Kawanishi, S., Oikawa, S. (2007). H2O2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion. Cell Physiol Biochem 20:45–54.
   PubMed Web of Science ®Google Scholar
• Hammes, T. O., Pedroso, G. L., Hartmann, C. R., Escobar, T. D., Fracasso, L. B., da Rosa, D. P., et al. (2012). The effect of taurine on hepatic steatosis induced by thioacetamide in zebrafish (Danio rerio). Dig Dis Sci 57:675–682.
   PubMed Web of Science ®Google Scholar
• Hasegawa, K., Wakino, S., Yoshioka, K., Tatematsu, S., Hara, Y., Minakuchi, H., et al. (2008). Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem Biophys Res Commun 72:51–56.
   Google Scholar
• Immenschuh, S., Baumgart-Vogt, E., Mueller, S. (2010). Heme oxygenase-1 and iron in liver inflammation: a complex alliance. Curr Drug Targets 11:1541–1550.
   PubMed Web of Science ®Google Scholar
• Jackson, M. D., Schmidt, M. T., Oppenheimer, N. J., Denu, J. M. (2003). Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases. J Biol Chem 278:50985–50998.
   PubMed Web of Science ®Google Scholar
• Kondo, T., Suda, T., Fukuyama, H., Adachi, M., Nagata, S. (1997). Essential roles of the Fas ligand in the development of hepatitis. Nat Med 3:409–413.
   PubMed Web of Science ®Google Scholar
• Ling, P. R., Smith, R. J., Kie, S., Boyce, P., Bistrian, B. R. (2004). Effects of protein malnutrition on IL-6-mediated signaling in the liver and the systemic acute-phase response in rats. Am J Physiol Regul Integr Comp Physiol 287:R801–R808.
   PubMed Web of Science ®Google Scholar
• Malhi, H., Gores, G. J. (2008). Cellular and molecular mechanisms of liver injury. Gastroenterology 134:1641–1654.
   PubMed Web of Science ®Google Scholar
• Ohta, Y., Imai, Y., Matsura, T., Kitagawa, A., Yamada, K. (2006). Preventive effect of neutropenia on carbon tetrachloride-induced hepatotoxicity in rats. J Appl Toxicol 26:178–186.
   PubMed Web of Science ®Google Scholar
• Pfluger, P. T., Herranz, D., Velasco-Miguel, S., Serrano, M., Tschop, M. H. (2008). Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A 105:9793–9798.
   PubMed Web of Science ®Google Scholar
• Purushotham, A., Schug, T. T., Xu, Q., Surapureddi, S., Guo, X., Li, X. (2009). Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 9:327–338.
   PubMed Web of Science ®Google Scholar
• Purushotham, A., Xu, Q., Lu, J., Foley, J. F., Yan, X., Kim, D. H., et al. (2012). Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice. Mol Cell Biol 32:1226–1236.
   PubMed Web of Science ®Google Scholar
• Rajendrasozhan, S., Yang, S. R., Kinnula, V. L., Rahman, I. (2008). SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:861–870.
   PubMed Web of Science ®Google Scholar
• Schug, T. T., Li, X.. (2011). Sirtuin 1 in lipid metabolism and obesity. Ann Med 43:198–211.
   PubMed Web of Science ®Google Scholar
• Schug, T. T., Xu, Q., Gao, H., Peres-da-Silva, A., Draper, D. W., Fessler, M. B., et al. (2010). Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol Cell Biol 30:4712–4721.
   PubMed Web of Science ®Google Scholar
• Shen, Z., Ajmo, J. M., Rogers, C. Q., Liang, X., Le, L., Murr, M. M., et al. (2009). Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am J Physiol Gastrointest Liver Physiol 296:G1047–G1053.
   PubMed Web of Science ®Google Scholar
• Smith, B. C., Hallows, W. C., Denu, J. M. (2008). Mechanisms and molecular probes of sirtuins. Chem Biol 15:1002–1013.
   PubMed Web of Science ®Google Scholar
• Sprague, C. L., Elfarra, A. A. (2005). Protection of rats against 3-butene-1,2-diol-induced hepatotoxicity and hypoglycemia by N-acetyl-l-cysteine. Toxicol Appl Pharmacol 207:266–274.
   PubMed Web of Science ®Google Scholar
• Taniguchi, M., Takeuchi, T., Nakatsuka, R., Watanabe, T., Sato, K. (2004). Molecular process in acute liver injury and regeneration induced by carbon tetrachloride. Life Sci 75:1539–1549.
   PubMed Web of Science ®Google Scholar
• Wang, R. H., Kim, H. S., Xiao, C., Xu, X., Gavrilova, O., Deng, C. X. (2011). Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. J Clin Invest 121:4477–4490.
   PubMed Web of Science ®Google Scholar
• Weber, L. W., Boll, M., Stampfl, A. (2003). Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33:105–136.
   PubMed Web of Science ®Google Scholar
• Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., et al. (2004). Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369–2380.
   PubMed Web of Science ®Google Scholar
• Zhang, R., Chen, H. Z., Liu, J. J., Jia, Y. Y., Zhang, Z. Q., Yang, R. F., et al. (2010a). SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J Biol Chem 285:7097–7110.
   PubMed Web of Science ®Google Scholar
• Zhang, J., Lee, S. M., Shannon, S., Gao, B., Chen, W., Chen, A., et al. (2009). The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. J Clin Invest 119:3048–3058.
   PubMed Web of Science ®Google Scholar
• Zhang, H. N., Li, L., Gao, P., Chen, H. Z., Zhang, R., Wei, Y. S., et al. (2010b). Involvement of the p65/RelA subunit of NF-kappaB in TNF-alpha-induced SIRT1 expression in vascular smooth muscle cells. Biochem Biophys Res Commun 397:569–575.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Wan, J., Li, H., Wu, P., Jin, S., Zhou, X., et al.. (2007). Protective effects of BML-111, a lipoxin A(4) receptor agonist, on carbon tetrachloride-induced liver injury in mice. Hepatol Res 37:948–956.
   PubMed Web of Science ®Google Scholar